<?xml version="1.0" encoding="UTF-8"?>
<p id="Par12">In these 155 pooled clinical trials, a number of approved chemical and biomacromolecule drugs have been used in COVID-19 treatment clinical trials for drug repurposing, most of which are nucleotide analogs and protease inhibitors against other viral pathogens, including influenza virus, HIV and HCV. Comprehensive information about the chemical agents used in COVID-19 drug clinical trials is shown in the table belowÂ (Table 
 <xref rid="Tab1" ref-type="table">1</xref>).
</p>
